Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience
Journal of Psychoactive Drugs May 22, 2026 Jamie Walker, Daryle Deering, Bruno Hamish Unger
Opioid dependence is a public health concern in New Zealand, with limited treatment options beyond opioid substitution therapy (OST). Ibogaine, a psychoactive alkaloid with reported anti-withdrawal and anti-craving effects for opioid dependence, is legally available by prescription in New Zealand, offering a context for exploring user experiences. A qualitative collective case study design was...